Homebiotech

biotech

biotech

Colospan announces positive results from intraoperative tissue assessment technology

Jim Cornall - August 26, 2026

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

Advancing Aramchol-based therapeutics

Jim Cornall - May 13, 2026

biotech

CRISPR inhibits hepatitis E virus

Jim Cornall - May 13, 2026

biotech

Biotech searches for alternative to Red 40

Jim Cornall - May 12, 2026

biotech

Antibody spurs nerve fibre regrowth after spinal cord injury

Jim Cornall - May 12, 2026

biotech

Basel life sciences supercluster welcomes Korean biopharmas

Jim Cornall - May 12, 2026

biotech

Study shows IL-23 inhibitor demonstrates efficacy in perianal fistulizing Crohn’s disease

Jim Cornall - May 11, 2026

biotech

Hand-held probe maps cancerous tissue

Jim Cornall - May 11, 2026

biotech

Cells “back up” DNA replication to survive damage

Jim Cornall - May 11, 2026

1...202122...96 Page 21 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Colospan announces positive results from intraoperative tissue assessment technology

Jim Cornall - August 26, 2026 0

Colospan Ltd., a wholly owned subsidiary of Galmed Pharmaceuticals Ltd., has successfully completed a feasibility study supporting the development of a novel intraoperative colon...

New norovirus vaccine approach may help treat other RNA viruses

biotech Jim Cornall - August 25, 2026 0

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0